Latest filing published 21 May 2026 for Fate Therapeutics INC, €47k.
Filing timeline
BuySaleInsider track record
Bahram Valamehr: trading record in brief
Bahram Valamehr is a declared insider of Fate Therapeutics Inc, with filings sourced from SEC (Form 4). The record holds 76 filings, for trades running from 7 January 2019 to 4 August 2026.
Sales make up the whole of the open-market record (55 sales, €12.2M). Outside the open market, there are 7 share grants and 14 option exercises. In 2026 alone, the filings show no purchases and 3 sales.
The latest filing, published on 5 August 2026, reports an open-market sale of €94k in Fate Therapeutics Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Bahram Valamehr
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 28,946 shares@ US$1.88220.018% mcap5.0% of flowCommon StockSEC:0001193125-26-234380:0
- 335,000 shares0Common StockSEC:0001193125-26-015294:0
- 5,190 shares@ US$1.07080.5% of flowCommon StockSEC:0001193125-26-010352:0
- 14,466 shares@ US$1.06431.4% of flowCommon StockSEC:0000950170-25-102979:0
- 8,705 shares@ US$1.541.4% of flowCommon StockSEC:0000950170-25-004814:0
- 200,000 shares0Common StockSEC:0000950170-24-088775:0
- 11,271 shares@ US$4.384.8% of flowCommon StockSEC:0000950170-24-003650:0
- 423 shares@ US$1.370.1% of flowCommon StockSEC:0001209191-23-003261:0
- 10,917 shares@ US$5.245.7% of flowCommon StockSEC:0001209191-23-002978:0
- 17,158 shares@ US$30.2314.3% of flowCommon StockSEC:0001209191-22-041670:1
- 17,158 shares@ US$2.734.9% of flowCommon StockSEC:0001209191-22-041670:0
- 5,842 shares@ US$2.730.4% of flowCommon StockSEC:0001209191-22-041440:1
- 7,842 shares@ US$30.076.5% of flowCommon StockSEC:0001209191-22-041440:2
- 2,000 shares@ US$4.841.0% of flowCommon StockSEC:0001209191-22-041440:0
- 16,678 shares@ US$30.3613.0% of flowCommon StockSEC:0001209191-22-018820:1
- 3,067 shares@ US$31.662.5% of flowCommon StockSEC:0001209191-22-018820:2
- 2,195 shares@ US$32.491.8% of flowCommon StockSEC:0001209191-22-018820:3
- 2,960 shares@ US$33.302.5% of flowCommon StockSEC:0001209191-22-018820:4
- 100 shares@ US$34.040.1% of flowCommon StockSEC:0001209191-22-018820:5
- 25,000 shares@ US$2.736.7% of flowCommon StockSEC:0001209191-22-018820:0
- 33,302 shares0Common StockSEC:0000899243-22-003449:0
- 418 shares@ US$49.12Common StockSEC:0001209191-22-003170:1
- 4,152 shares@ US$48.4418.9% of flowCommon StockSEC:0001209191-22-003170:0
- 351 shares@ US$47.17Common StockSEC:0001209191-22-003047:1
- 5,245 shares@ US$46.3322.8% of flowCommon StockSEC:0001209191-22-003047:0
25 of 75 declarations
